TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Benzer Materyaller

• TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
  Yazar:: Welch, John S., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
  Yazar:: Becker, Heiko, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block
  Yazar:: Jiexian Ma, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-02-01)
• The TP53 Pro72Arg SNP in de novo acute myeloid leukemia
  Yazar:: Schulz, Eduard, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
  Yazar:: Bezerra, Matheus F., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)